A pilot initiative for the digital tracking and labeling of medical devices is advancing in Uzbekistan, designed to allow manufacturers and distributors to evaluate operational systems ahead of mandatory implementation. The testing mechanism gives pharmaceutical market participants an opportunity to upgrade production equipment, align internal data networks, and resolve supply chain bottlenecks before stringent compliance protocols take full legal effect.

Practical experience under the scheme was detailed by the representative office of Hungary-based manufacturer Gedeon Richter. According to Nigora Makhsudkhanova, head of the firm's regulatory department in Uzbekistan, the company utilized protocols established during previous pharmaceutical labeling programs. Specialists underwent technical training with representatives of the Asl Belgisi National Information System, synchronizing registration procedures, code generation, and DataMatrix integration through the state Tasnif Soliq tax platform.

The integration of unique digital identifiers goes far beyond standard factory-floor labeling, fundamentally altering commercial workflows. Departments covering sales, procurement, freight logistics, and stock inventory have had to synchronize operations to adjust packaging layouts and prevent logistical disruptions. For the healthcare sector, where stability of clinical supplies remains vital, eliminating potential bottlenecks during this preliminary stage is deemed crucial.

The pilot phase also serves the operator of the Asl Belgisi system by revealing practical friction points within actual distribution networks. Comprehensive traceability relies heavily on the technical readiness of all commercial participants; ongoing feedback from operational enterprises enables authorities and system developers to refine software interfaces and provide regulatory guidance before mandatory enforcement begins.

Source: podrobno.uz